GKOS Projected Dividend Yield
Glaukos Corp ( NYSE : GKOS )Glaukos Corporation is an ophthalmic pharmaceutical and medical technology company developing dropless therapies for glaucoma, corneal disorders, and retinal disease. Its products include Micro-Invasive Glaucoma Surgery devices to reduce intraocular pressure by restoring natural aqueous humor outflow, intracameral drug delivery technologies for sustained glaucoma medication, transdermal pharmaceuticals for glaucoma, dry eye, presbyopia, and other ocular diseases, and bio-erodible sustained release drug delivery implants to improve vision. 21 YEAR PERFORMANCE RESULTS |
GKOS Dividend History Detail GKOS Dividend News GKOS Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |